BioMarker Pharmaceuticals, Inc.
Records under this name other than patents BioMarker Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to BioMarker Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,016,476 | Nutrient Combinations for Affecting an Aging Process Lapsed on the fee record Ended Jul 10, 2026 · High confidence | Lapsed on the fee record | Ended Jul 10, 2026 | High confidence |
| US 8,436,224 | Methods for testing for caloric restriction (CR) mimetics Lapsed on the fee record Ended May 7, 2025 · USPTO record | Lapsed on the fee record | Ended May 7, 2025 | USPTO record |
| US 8,403,844 | Methods for interventions Lapsed on the fee record Ended Mar 26, 2025 · USPTO record | Lapsed on the fee record | Ended Mar 26, 2025 | USPTO record |
| US 9,138,453 | Nutrient Combinations for Affecting an Aging Process Lapsed on the fee record Ended Sep 22, 2023 · High confidence | Lapsed on the fee record | Ended Sep 22, 2023 | High confidence |
| US 7,960,605 | Methods for testing for caloric restriction (CR) mimetics Lapsed on the fee record Ended Jun 14, 2023 · USPTO record | Lapsed on the fee record | Ended Jun 14, 2023 | USPTO record |
| US 8,692,051 | Methods for testing for caloric restriction (CR) mimetics Lapsed on the fee record Ended Apr 8, 2022 · USPTO record | Lapsed on the fee record | Ended Apr 8, 2022 | USPTO record |